Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKeir, A.-
dc.contributor.authorMcPhee, A.-
dc.contributor.authorAndersen, C.-
dc.contributor.authorStark, M.-
dc.identifier.citationPediatric Research, 2013; 73(1):75-79-
dc.description.abstractBACKGROUND: Transfusion of packed red blood cells (PRBCs) saves lives in the neonatal critical care setting and is one of the most common interventions in the preterm infant. The number and volume of PRBC transfusions are associated with several major neonatal morbidities, although a direct causal link between transfusion and major neonatal morbidity is still to be proven. Transfusion-related immunomodulation (TRIM) may underlie these adverse outcomes, yet it has received little attention in the high-risk preterm infant. METHODS: One transfusion event was studied in infants ≤28 wk gestation between 2 and 6 wk postnatal age (n = 28). Plasma inflammatory cytokines and markers of endothelial activation were measured in the infants before and 2–4 h after transfusion, as well as in the donor pack. RESULTS: Median (range) age at transfusion was 18 (14–39) days with the pretransfusion hemoglobin level at 9.8 (7.4–10.2) g/dl. Interleukin (IL)-1β (P = 0.01), IL-8 (P = <0.001), tumor necrosis factor-α (P = 0.008), and monocyte chemoattractant protein (P = 0.01) were increased after transfusion. A similar elevation in markers of endothelial activation was seen after transfusion with increased plasma macrophage inhibitory factor (P = 0.005) and soluble intracellular adhesion molecule-1 (P = <0.001). CONCLUSION: Production of inflammatory cytokines and immunoactivation of the endothelium observed after the transfusion of PRBCs in the preterm infant may be a manifestation of TRIM. The implications of this emerging phenomenon within the preterm neonatal population warrant further investigation.-
dc.description.statementofresponsibilityAmy K. Keir, Andrew J. McPhee, Chad C. Andersen and Michael J. Stark-
dc.publisherInt Pediatric Research Foundation Inc-
dc.rights© 2013 International Pediatric Research Foundation, Inc.-
dc.subjectTumor Necrosis Factor-alpha-
dc.subjectPlasminogen Activator Inhibitor 1-
dc.subjectMonocyte Chemoattractant Proteins-
dc.subjectErythrocyte Transfusion-
dc.subjectStatistics, Nonparametric-
dc.subjectInfant, Newborn-
dc.subjectFas Ligand Protein-
dc.subjectInfant, Extremely Premature-
dc.titlePlasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant-
dc.typeJournal article-
dc.identifier.orcidKeir, A. [0000-0003-1692-5676]-
dc.identifier.orcidMcPhee, A. [0000-0003-3820-5696]-
dc.identifier.orcidAndersen, C. [0000-0002-1364-4986]-
dc.identifier.orcidStark, M. [0000-0003-1835-8679]-
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.